Annals of Hematology

Article	Citations
A case of acute promyelocytic leukemia with pericardial effusion successfully managed with colchicine during ATO administration	66
Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate	55
Refractory hepatosplenic T-cell lymphoma was successfully treated with salvage allogeneic hematopoietic stem cell transplantation combined with enhanced myeloablative preconditioning	50
Trimethoprim-sulfamethoxazole prevents interstitial pneumonitis in B-cell lymphoma patients receiving chemotherapy: a propensity score matching analysis	46
Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing/refractory multi-lineage autoimmune cytopenia	46
Correction to: Hemophagocytic lymphohistiocytosis in HIV-associated lymphoproliferative disorders	45
Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive acute lymphoblastic leukemia	44
Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study	42
Sufficient vitamin D is favorable for children with persistent and chronic immune thrombocytopenia	39
Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children’s Cancer Group study ALL-2015	39
Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma	37
Advances in the ocular complications after hematopoietic stem cell transplantation	36
The presence of idiopathic thrombocytopenic purpura and incidence of acute non-ST elevation myocardial infarction	36
CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study	33
CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease	31
Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group	31
Clonal evolution analysis of a rare acute promyelocytic leukemia patient transforming from essential thrombocythemia	31
Detection of circulating tumor DNA in cerebrospinal fluid prior to diagnosis of spinal cord lymphoma by flow cytometric and cytologic analyses	30
Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experienc	27
Analysis of incidence and risk factors of the multidrug resistant gastrointestinal tract infection in children and adolescents undergoing allogeneic and autologous hematopoietic cell transplantation:	26
Outcome of patients with diffuse large B-cell lymphoma and testicular involvement – real world data	23
Refractory pure red cell aplasia associated with T-cell large granular lymphocyte leukemia treated by ruxolitinib	23
Basophilia and eosinophilia in polycythemia vera and essential thrombocythemia: clinical, genotype, and prognostic correlates	22
Optimizing hemophagocytic lymphohistiocytosis screening in children: validation of the HLH-Screen score	22
Safe administration of venetoclax-obinutuzumab in a chronic lymphocytic leukemia patient with Brugada syndrome	22

Activity of trametinib as maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory RAS pathway-mutated hematologic malignancies	21
Licochalcone A decreases cancer cell proliferation and enhances ferroptosis in acute myeloid leukemia through suppressing the IGF2BP3/MDM2 cascade	21
Health-related quality of life with daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible patients with newly diagnosed multipl	21
Incidence of pneumonia among bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: a systematic review and meta-analysis of clinical trials	20
Nomogram for predicting survival of patients with diffuse large B-cell lymphoma	20
Radiotherapy alone with curative intent in a case of limited-stage extranodal NK/T-cell lymphoma nasal type: a case report and review of the literature	20
Leukemia cutis in accelerated chronic lymphocytic leukemia: successful treatment with venetoclax and rituximab	20
Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives	20
Treatment patterns and healthcare resource utilization in ruxolitinib-treated patients with myelofibrosis with and without anemia: a real-world analysis	19
Ferroptosis: a new target for iron overload-induced hemophilic arthropathy synovitis	19
Correction to: Delphi consensus recommendations on treatment for advanced-stage marginal zone lymphoma in South Korea	18
Global, regional and national temporal trends in incidence and mortality of non-Hodgkin lymphoma from 1992 to 2021: an age-period-cohort analysis	18
Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients’ outcome	18
Molecular profiling of cell-free DNA from classic Hodgkin lymphoma patients identifies potential prognostic clusters and corresponds with disease dynamics	18
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia	17
Germline mutations predispose a concurrent thymoma and diffuse large B-cell lymphoma	16
Symposium Proceedings of the international symposium ACUTE LEUKEMIAS XIX (ISALXIX), Munich March 16–19, 2025	16
A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia	16
Absence of blood donors’ anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients	16
Impact of induction regimens on stem cell mobilization yields in newly diagnosed multiple myeloma	16
Intramural esophageal hematoma precipitated by acquired factor XI deficiency in a patient with relapsed T cell prolymphocytic leukemia after allogeneic hematopoietic cell transplantation	16
Eltrombopag in the treatment of patients with persistent thrombocytopenia after haploidentical peripheral blood stem cell transplantation: a single-center experience	15
Paroxysmal nocturnal haemoglobinuria in pregnancy–a systematic review with meta analysis	15
A randomized controlled trial of thrice-weekly versus thrice-daily oral ferrous fumarate treatment in adult patients with iron-deficiency anemia	15
Maternal factors associated with iron deficiency without anaemia in early pregnancy: ECLIPSES study	15
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma	14
Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis	14
Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension	14
Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants	14
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrosp	14
Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments	14
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts	14
Circulating tumor DNA assisting lymphoma genetic feature profiling and identification	14
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience	14
Predictive factors of romiplostim response in patients with refractory aplastic anemia: data from two clinical trials	13
TGFBI regulates the TGF-β pathway to affect the malignant progression and cisplatin sensitivity in diffuse large B-cell lymphoma	13
Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience	13
Mutational heterogeneity in large B-cell lymphoma: insights from paired biopsies	13
Adipocyte fatty acid-binding protein (FABP4) as a potential biomarker for predicting metabolically driven low-grade and organ damage in thalassemia syndromes	13
Detection of pulse rate elevation by Apple Watch in a patient with bronchiolitis obliterans syndrome after allogeneic stem cell transplantation	13
Non-Hodgkin lymphomas and ionizing radiation: case report and review of the literature	13
Reporting of adverse events of treatment interventions in multiple myeloma: an overview of systematic reviews	13
Bilateral deafness in NK/T-cell lymphoma: EBV DNA prevailed over magnetic resonance imaging	13
Cerebral infarction in a patient with inhibitor-positive hemophilia B treated with plasma-derived factor VIIa and factor X mixture	13
Post-transplant lymphoproliferative disease of two different histological types	13
Radiation hazards of the Ukraine nuclear power plants: how can international blood and marrow stem cell transplant societies help?	13
Sex differences in fatigue and symptoms of anemia in relation to hemoglobin level in hospitalized patients	13
A novel WNK1::PDGFRB fusion gene in myeloid neoplasm with eosinophilia: a case report	12
The first successful expanded compassionate use of Iptacopan in a patient with paroxysmal nocturnal hemoglobinuria	12
Specificity protein 1/3 regulate T-cell acute lymphoblastic leukemia cell proliferation and apoptosis through β-catenin by acting as targets of miR-495-3p	12

Correction to: Spanish registry of hemoglobinopathies and rare anemias (REHem- AR): demographics, complications, and management of patients with β-thalassemia	12
Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab	12
Acute promyelocytic leukemia derived extracellular vesicles conserve PML-RARα transcript from storage-inflicted degradation: a stable diagnosis tool in APL patients	12
Achievement of rapid complete remission in an 87-year-old female patient with azacytidine-venetoclax for blastic plasmacytoid dendritic cell neoplasm	12
CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression—a potential differential diagnostic pitfall between PTLD and PTSMT	12
Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma	12
Advances in epigenetic therapies for B-cell non-hodgkin lymphoma	12
Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study	12
Correction to: Potential risk factors for the development from immune thrombocytopenia to systemic lupus erythematosus: a case–control study in Chinese children	12
Clinical features and outcomes of 17 children with systemic juvenile xanthogranuloma (sJXG) including five complicated with hemophagocytic lymphohistiocytosis (HLH)	11
Critical risk factors analysis of infection-associated hemophagocytic lymphohistiocytosis in children	11
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics	11
Successful rechallenge with azacytidine and venetoclax after sustained treatment-free remission in a relapsed acute myeloid leukemia patient: a case report	11
A multicentre ambispective observational study into the incidence and clinical management of aplastic anaemia in Spain (IMAS study)	11
Midostaurin added to 10-day decitabine, for patients unfit for intensive chemotherapy with AML and higher risk MDS, irrespective of FLT3 mutational status, does not improve outcome	11
Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Inf	11
Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL)	11
Identification of CD105 (endoglin) as novel risk marker in CLL	11
Low-dose venetoclax combined with azacitidine for blastic plasmacytoid dendritic cell neoplasm: a case report and literature review	11
Life-threatening paraneoplastic cardiovascular events in ALK-positive anaplastic large cell lymphoma	11
Molecular response with asciminib 20 mg QD in a patient intolerant to multiple TKIs	10
Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematol	10
Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin’s lymphoma: A single-center prospective study	10
Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry	10
Altered serum lipid levels are associated with prognosis of diffuse large B cell lymphoma and influenced by utility of rituximab	10
Safety and efficacy of daratumumab in Chinese patients with relapsed or refractory multiple myeloma: a phase 1, dose-escalation study (MMY1003)	10
An unexpected find of multifocal extranodal marginal zone lymphoma	10
Practical considerations in the management of patients treated with bosutinib for chronic myeloid leukemia	10
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes	10
Efficacy and safety of new-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia/small lymphocytic lymphoma: a systematic review and meta-analysis	10
Severe platelet transfusion refractoriness due to anti-HPA-5a antibody during induction chemotherapy for acute promyelocytic leukemia	10
Analysis of Wilms’ tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed	10
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide conditioning in patients with central nervous system lymphoma: a phase II study	10
Prognostic significance of early nk cell recovery in pediatric t-cell replete allogeneic hematopoietic stem cell transplantation	9
Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective	9
Efficacy of venetoclax combined with decitabine conditioning regimen for allogeneic hematopoietic stem cell transplantation in high-risk and elderly patients with myeloid neoplasms	9
Incidence and reasons for discontinuation of first-line therapy in patients with multiple myeloma: results from a historical cohort, Brazil 2009–2020	9
Impact of baseline and interim quantitative PET parameters on outcomes of classical Hodgkin Lymphoma	9
COVID-19: impact of vaccination in myeloma patients	9
Chronic neutrophilic leukemia with JAK2 mutation: is it true chronic neutrophilic leukemia?	9
Sickle cell disease and opioid overdose outcomes in the United States: a nationwide analysis	9
Epigenetically dysregulated NOTCH-Delta-HES signaling cascade can serve as a subtype classifier for acute lymphoblastic leukemia	9
Identification of a novel cryptic variant chromosomal rearrangement involving 9q34, 22q11.2, and 5q22 resulting in ins(9;22) and t(5;22) in chronic myeloid leukemia: a case report	9
Re-induction therapy in patients with acute myeloid leukemia not in complete remission after the first course of treatment	9
Patient-reported outcome domains in multiple myeloma randomized controlled trials and association with survival outcomes	9
Management of paroxysmal nocturnal hemoglobinuria with low-level hemolysis in pregnancy– a report of two cases	9
Are accessory spleen screening and resection in refractory immune cytopenia an effective strategy or a waste of resources?	9
Acute liver failure associated with human adenovirus infection after allogeneic hematopoietic stem cell transplantation	9
Pseudothrombocytopenia, beyond a laboratory phenomenon: study of 192 cases	9
Clinical prognostic value of different NPM1 mutations in acute myeloid leukemia patients	9
Real-world challenges in the management of acute myeloid leukemia: a single-center experience from North India	9
Multiplex digital PCR enables sensitive detection of resistance to BTK inhibitors	9
Treatment of refractory or relapsed myelodysplastic neoplasms with luspatercept: a multicenter Chinese study	9
Characteristics of inpatients with newly diagnosed multiple myeloma in hematology, nephrology, and orthopedic departments	9
Post-transplant transient abnormal myelopoiesis evolving from a GATA1 mutant clone in umbilical cord blood	9
Zebrafish modeling of atypical PML-RARA isoform from acute promyelocytic leukemia patient and its implications for clinical treatment	9
Next-generation sequencing redefines the diagnosis of triple-negative myeloproliferative neoplasms	9
Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report	9
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report	8
Relationship between subtype-specific minimal residual disease level and long-term prognosis in children with acute lymphoblastic leukemia	8
Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial	8
A new score for predicting intracranial hemorrhage in patients using antiplatelet drugs	8
Optimal dosage of rituximab for children with Burkitt lymphoma	8
Donor’s age influences outcome in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide - a single center experience	8
Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccination	8
Mendelian randomization of circulating proteome identifies IFN-γ as a druggable target in aplastic anemia	8
No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey	8
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience	8
Interim PET in follicular lymphoma: more patience, please	8
Liquid biopsies of plasma and cerebrospinal fluid are useful for detection of intravascular lymphoma with central nervous system symptoms alone	8
Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM)	8
Platelet recovery with ibrutinib therapy in patient with treatment-refractory immune thrombocytopenia	8
2-[18]F FDG PET/CT dissemination features in adult burkitt lymphoma Are predictive of outcome	8
Benefit of high-dose idarubicin as induction therapy in acute myeloid leukemia: a prospective phase 2 study	8
In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation	8
A case of JAK2 V617F positive essential thrombocythemia successfully controlled by imatinib mesylate	8
Bibliometric analysis of worldwide research on Polycythemia Vera in the 21st century	8
Overcoming right heart failure through successful treatment of cardiac dominant diffuse large B-cell lymphoma: a case report	8
Is comprehensive geriatric testing guiding in the identification of multiple myeloma patients who are candidates for autologous stem cell transplantation? A prospective analysis	8
Immune reconstitution and survival of patients with parvovirus B19 related pure red cell aplasia after haplo-PBSCT	8

A comparative study of platelet storage lesion in platelet-rich plasma under cryopreservation	7
Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?	7
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial	7
Anticoagulation strategies and recurrence of venous thromboembolic events in patients with sickle cell disease: a systematic review and meta-analysis	7
Validity of the criteria for clinical transformation of follicular lymphoma: analysis of a mostly biopsied cohort	7
Comparable clinical outcomes of haploidentical hematopoietic stem cell transplantation in patients with hepatitis-associated aplastic anemia and non-hepatitis-associated aplastic anemia	7
Functional apoptosis profiling reveals vulnerabilities in T-cell large granular lymphocytic leukemia	7
VEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant management	7
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation	7
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey	7
The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemia	7
ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies	7
Prognostic value of metabolic tumor volume of extranodal involvement in diffuse large B cell lymphoma	7
The roles of ubiquitination in AML	7
Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations	7
Risk factors and outcomes of cytomegalovirus infection in children post cord blood transplantation with focus on impact of graft-versus-host disease and immunosuppressants	7
Association between low incidence of TP53 mutations and reduced early relapse rates in Uygur DLBCL	7
Safe utilization of ruxolitinib in simultaneous primary myelofibrosis and warm autoimmune hemolytic anemia	7
Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study	7
Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatory	7
Association between N-acetylcysteine treatment and in-hospital mortality in adult patients with acquired thrombotic thrombocytopenic purpura: a cohort study	7
Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL)	7
Analysis of PROS1 mutations and clinical characteristics in three Chinese families with hereditary protein S deficiency	7
Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation	7
The experience of diagnosis and treatment for TAFRO syndrome	7
Characteristics and outcomes of COVID-19 in patients with plasma cell dyscrasias during the first Omicron wave in Beijing since December 2022: a retrospective study at a National Clinical Research Cen	7
Development of disseminated intravascular coagulation in asymptomatic leukemic non-nodal mantle cell lymphoma	7
A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin’s lymphoma	7
An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma	7
Initial management of patients with acquired aplastic anemia in the United States: results from a large national claims database	7
Association of inflammation and abnormal lipid metabolism with risk of thrombosis and thrombosis progression in patients with polycythemia vera: a retrospective study	7
miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia	7
Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use	7
Estimating prognostic relevant cutoff values for a multiplex PCR detecting BCR::ABL1 in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy in resource-limited settings	7
Enhancing outcomes of childhood acute lymphoblastic leukemia in workplace diversity in Thailand: multicenter study on behalf of the Thai Pediatric Oncology Group	7
Feasibility of allogeneic stem cell transplantation (HSCT) in patients with acute myeloid leukemia previously treated with CPX-351: report from a single center	7
Case report:Clinical manifestations and therapeutic options following rhTPO-induced neutralizing antibody production in a child with immune thrombocytopenia	7
Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study	7
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis	7
Early predictor for differentiation syndrome in newly diagnosed acute promyelocytic leukaemia patients treated with single-agent arsenic trioxide	7
A case report of dyskeratosis congenita caused by a novel TERC mutation	6
Real-world data of siltuximab for Chinese patients with iMCD: combination with BCD regimen as a potential approach for severe cases	6
T(11;14) with multiple myeloma: Standard risk survival but slow and poor response	6
Benefit of consolidative radiation in patients with extranodal limited-stage diffuse large B-cell lymphoma: a multicenter retrospective study in China	6
Molecular characteristics of hereditary red blood cell membrane disorders in Thailand: a multi-center registry	6
Expression of the immune checkpoint receptors CTLA-4, LAG-3, and TIM-3 in β-thalassemia major patients: correlation with alloantibody production and regulatory T cells (Tregs) phenotype	6
Impact of protein-energy malnutrition on outcomes of patients with sickle cell disease: an analysis of the National inpatient sample	6
Real-world experience of anti-D immunoglobulin in immune thrombocytopenia	6
Polatuzumab Vedotin, zanubrutinib and rituximab (Pola-ZR) achieved rapid and deep response in untreated frail and elderly DLBCL	6
Successful treatment with oseltamivir phosphate in children with ITP who failed first-line therapy: a case series report	6
Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphoma	6
CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia	6
Two cases of refractory IgG4-related disease successfully treated with tocilizumab	6
Recent advances in CD5+ diffuse large B-cell lymphoma	6
Bone marrow involvement is a risk factor for infusion-related reactions in patients with follicular lymphoma treated by obinutuzumab	6
Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination	6
Investigation of TSRP reverses imatinib resistance through the PI3K / Akt pathway in chronic myeloid leukemia	6
Three-year cardiovascular and non-cardiovascular adverse events in patients with chronic lymphocytic leukemia or small cell lymphocytic lymphoma treated with Bruton tyrosine kinase inhibitors acalabru	6
Polatuzumab vedotin and bendamustine (Pola-B) was effective for refractory CD20-negative double-expressor lymphoma	6
Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study	6
Speckle tracking echocardiography and β-thalassemia major. A systematic review	6
L-DEP regimen is effective as an initial therapy for adult EBV-HLH	6
Epstein-Barr virus–positive diffuse large B-cell lymphoma after frontline brentuximab vedotin treatment of classical Hodgkin lymphoma	6
Development and validation of nomogram prognostic model for predicting OS in patients with diffuse large B-cell lymphoma: a cohort study in China	6
Molecular genetics and management of world health organization defined atypical chronic myeloid leukemia	6
Clinical features and outcomes in large granular lymphocyte leukemia − associated pure red cell aplasia with STAT3 mutation	6
Development and validation of an early mortality risk model for pediatric hemophagocytic lymphohistiocytosis: a comparison with HScore, PELOD-2, P-MODS, and pSOFA	6
Mass cytometry analysis identifies T cell immune signature of aplastic anemia and predicts the response to cyclosporine	6
Correction to: One disease, two faces: clonally-related AML and MPDCP with skin involvement	6
N-Acetylcistein for thrombotic thrombocytopenic purpura: an observational case series study	6
The added value of digital morphological analysis in the evaluation of peripheral blood films: the report of an UKNEQAS external quality assessment sample	6
A synchronous therapy with daratumumab and enzymatic replacement therapy (ERT) in a patient with Gaucher disease and multiple myeloma	6
Clinical effect of CALR allele burden in patients with essential thrombocythemia	6
The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP)	6
Broadening perspectives: redefining the role of obesity in ITP	6
Changes in hemoglobin and clinical outcomes drive improvements in fatigue, quality of life, and physical function in patients with paroxysmal nocturnal hemoglobinuria: post hoc analyses from the phase	6
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)	6
Association between HLA-DRB1*04, HLA-DQB1*03, and HLA-DQB1*06 with alloimmunization in transfusion-dependent patients with thalassemia: the first case-control study in Iran	6
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study	6
The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation	6
Rhabdomyolysis induced by nelarabine	6
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma	6
Prognostic factors in patients with secondary hemophagocytic lymphohistioc ytosis in a Chinese cohort	6
Impact of gemtuzumab ozogamicin consolidation on hematopoietic stem cells (HSCs) mobilization in AML: analysis of 20 patients	6
How to combine multiple tools for the genetic diagnosis work-up of pediatric B-cell acute lymphoblastic leukemia	6
Autotaxin is a potential predictive marker for the development of veno-occlusive disease/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation	6
A predictive diagnostic model for refractory diffuse large B-cell lymphoma: a single-center retrospective cohort study	6
Alectinib maintenance therapy following cord blood transplantation for relapsed pediatric anaplastic large cell lymphoma with central nervous system involvement	6
A promising natural product in diffuse large B-cell lymphoma therapy by targeting PIM1	6
Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease	6
A case of visual impairment due to HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation in childhood acute myeloid leukemia-M2 subtype	6
Impact of antithymocyte globulin on blood cyclosporin A levels in aplastic anemia patients	6
Efficacy and safety analysis of China’s first 10% IVIg (RonsenGlob) therapy in treating adult ITP	6
Outcome of allogeneic hematopoietic stem cell transplant recipients admitted to the intensive care unit with a focus on haploidentical graft and sequential conditioning regimen: results of a retrospec	6
Outcomes of the transformation to diffuse large B-cell lymphoma in hodgkin lymphoma and indolent B-cell non-Hodgkin lymphoma: a population-based study	6